Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.15+0.15 (+5.00%)
Close on Nov 18, 2026Market cap $12.44MP/E –Yield –
Onconetix revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Onconetix's revenue for the twelve months ending Jun 30, 2026 was $645.82K, down 51.3% year over year. For fiscal 2025 it was $815.37K, down 67.7% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $815.37K | -67.7% |
| FY2024 | Dec 31, 2024 | $2.52M | +4217.3% |
| FY2023 | Dec 31, 2023 | $58.47K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $17.12K | -83.9% |
| Q1 FY2026 | Mar 31, 2026 | $21.46K | -78.9% |
| Q4 FY2025 | Dec 31, 2025 | $303.60K | -57.4% |
| Q3 FY2025 | Sep 30, 2025 | $303.65K | -25.4% |
| Q2 FY2025 | Jun 30, 2025 | $106.49K | -84.9% |
| Q1 FY2025 | Mar 31, 2025 | $101.63K | -85.5% |
| Q4 FY2024 | Dec 31, 2024 | $711.98K | – |
| Q3 FY2024 | Sep 30, 2024 | $406.86K | – |
| Q2 FY2024 | Jun 30, 2024 | $704.85K | – |
| Q1 FY2024 | Mar 31, 2024 | $700.43K | – |
See a number that looks wrong?